A hallmark of psoriasis is a highly proliferated and fenescrated micovascular network. The factors that regulate blood vessel proliferation in this disease are unknown. This proposal will determine the role of cyclic nucleotides and proto-oncogenes in cell replication and differentiation of both normal and psoriatic microvascular skin endothelial cells. Microvascular endothelial cells will be isolated from three types of psoriasis and a comprehensive library of these cells will be established a several growth passages. The responsiveness of the psoriatic cell to vasoactive agents that produce vessel changes in vivo (vasoactive amines, prostaglandins, neuropeptides) will be determined in vitro both biochemically and morphologically by measuring changes in intracellular levels of cyclic AMP and cyclic GMP an by endothelial cell contraction and gap formation in cell monolayers. The fine structure of the cells (cytoplasmic filaments, cell membranes, Weibel-Palade bodies) will be characterized by electron microscopy. Angiogenesis will be measured in cell monolayers by induction of new vessels by collagen gels and the modulation of 4 proto-oncogenes (c-ras, c- myc, c-sis, and c-fos) will be determined by Northern blot analysis. The fine structure of the normal and psoriatic vessels at each stage of differentation will be analyzed by electron microscopy. These studies will provide basic information on the biochemistry and ultrastructure of both the normal and psoriatic skin microvascular endothelial cell and will determine if the abnormalities in the growth of blood vessels in psoriasis can be traced to genetic defects in the regulation of cyclic nucleotides essential for cell growth and function.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Stanford University
Schools of Medicine
United States
Zip Code
Ritvaniemi, P; Korkko, J; Bonaventure, J et al. (1995) Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis Rheum 38:999-1004
Prockop, D J; Kuivaniemi, H; Tromp, G (1994) Molecular basis of osteogenesis imperfecta and related disorders of bone. Clin Plast Surg 21:407-13
Mansbridge, J; Murphy, B; Morhenn, V et al. (1994) The response of human dermal microvascular endothelial cells to hypoxia. Biochim Biophys Acta 1223:209-18
Mansbridge, J N; Grymes, R A; Karasek, M A (1992) Modification of proto-oncogene expression by phorbol esters in human dermal microvascular endothelial cells. Cell Mol Biol (Noisy-le-grand) 38:791-8
Lipton, B H; Bensch, K G; Karasek, M A (1992) Histamine-modulated transdifferentiation of dermal microvascular endothelial cells. Exp Cell Res 199:279-91
Lipton, B H; Bensch, K G; Karasek, M A (1991) Microvessel endothelial cell transdifferentiation: phenotypic characterization. Differentiation 46:117-33
Karasek, M A (1990) New developments in our understanding of the biology of psoriasis. Cutis 46:307-10
Tuder, R M; Karasek, M A; Bensch, K G (1990) Cyclic adenosine monophosphate levels and the function of skin microvascular endothelial cells. J Cell Physiol 142:272-83
Karasek, M A (1989) Microvascular endothelial cell culture. J Invest Dermatol 93:33S-38S